Title |
Endocardite aórtica e tricúspide em pacientes de hemodiálise com embolia sistêmica e pulmonar
|
---|---|
Published in |
Revista Brasileira de Terapia Intensiva, January 2015
|
DOI | 10.5935/0103-507x.20150031 |
Pubmed ID | |
Authors |
Silvia Aguiar Rosa, Nuno Germano, Ana Santos, Luis Bento |
Abstract |
This is a case report of a 43-year-old Caucasian male with end-stage renal disease being treated with hemodialysis and infective endocarditis in the aortic and tricuspid valves. The clinical presentation was dominated by neurologic impairment with cerebral embolism and hemorrhagic components. A thoracoabdominal computerized tomography scan revealed septic pulmonary embolus. The patient underwent empirical antibiotherapy with ceftriaxone, gentamicin and vancomycin, and the therapy was changed to flucloxacilin and gentamicin after the isolation of S. aureus in blood cultures. The multidisciplinary team determined that the patient should undergo valve replacement after the stabilization of the intracranial hemorrhage; however, on the 8th day of hospitalization, the patient entered cardiac arrest due to a massive septic pulmonary embolism and died. Despite the risk of aggravation of the hemorrhagic cerebral lesion, early surgical intervention should be considered in high-risk patients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 23 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 17% |
Other | 3 | 13% |
Student > Bachelor | 3 | 13% |
Student > Postgraduate | 3 | 13% |
Researcher | 2 | 9% |
Other | 1 | 4% |
Unknown | 7 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 30% |
Biochemistry, Genetics and Molecular Biology | 2 | 9% |
Psychology | 2 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Economics, Econometrics and Finance | 1 | 4% |
Other | 0 | 0% |
Unknown | 10 | 43% |